Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5 Years Hemodynamic and Clinical Follow-up of the SAPIEN 3 Transcatheter Heart Valve According to the Implantation Strategy: Insight From the Randomized DIRECTAVI Trial

NCT05140317 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05140317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05140317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5 Years Hemodynamic and Clinical Follow-up of the SAPIEN 3 Transcatheter Heart Valve According to the Implantation Strategy: Insight From the Randomized DIRECTAVI Trial
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
August 1, 2023
Enrollment
236 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary syndrome, hemodynamic instability